Overcoming Challenges to Childhood Immunizations Status

Pediatric Clinics of North America
Svapna S Sabnis, James H Conway

Abstract

Vaccines are one of the greatest public health achievements, preventing both mortality and morbidity. However, overall immunization rates are still below the 90% target for Healthy People 2020. There remain significant disparities in immunization rates between children of different racial/ethnic groups, as well as among economically disadvantaged populations. There are systemic issues and challenges in providing access to immunization opportunities. In addition, vaccine hesitancy contributes to underimmunization. Multiple strategies are needed to improve immunization rates, including improving access to vaccines and minimizing financial barriers to families. Vaccine status should be assessed and vaccines given at all possible opportunities.

References

Jan 10, 1998·JAMA : the Journal of the American Medical Association·D WoodN Duan
Oct 12, 2000·American Journal of Preventive Medicine·J M SantoliE Brink
Oct 12, 2000·JAMA : the Journal of the American Medical Association·P G SzilagyiL E Rodewald
Apr 9, 2001·American Journal of Public Health·J S RotaE J Gangarosa
Sep 28, 2002·American Journal of Preventive Medicine·Jorge RosenthalLance Rodewald
Jan 10, 2003·The Cochrane Database of Systematic Reviews·P SzilagyiL Rodewald
Aug 13, 2003·Seminars in Pediatric Infectious Diseases·D A GustB Hibbs
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan R HinmanLance Rodewald
Aug 18, 2004·Public Health Reports·Barbara H BardenheierSusan Y Chu
May 4, 2005·Archives of Pediatrics & Adolescent Medicine·Daniel A SalmonNeal A Halsey
May 27, 2005·Preventive Medicine·Richard Kent ZimmermanBarbara P Yawn
Nov 29, 2005·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Thad R WilsonStanley A Edlavitch
Dec 7, 2005·Archives of Pediatrics & Adolescent Medicine·Fangjun ZhouRafael Harpaz
Jun 9, 2006·Health Promotion Practice·Sally E FindleyFrank Chimkin
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Saad B OmerDaniel A Salmon
Nov 3, 2007·Pediatrics·Noëlle-Angélique M MolinariRichard A Schieber
Nov 15, 2007·JAMA : the Journal of the American Medical Association·Sandra W RoushUNKNOWN Vaccine-Preventable Disease Table Working Group
Nov 21, 2007·American Journal of Preventive Medicine·Allison KempeStephen Berman
Sep 19, 2008·American Journal of Public Health·Sally E FindleyRaquel Andres-Martinez
Oct 3, 2008·Pediatrics·Deborah A GustBen Schwartz
Jan 8, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Sally E FindleyShaofu Chen
Apr 20, 2011·Pediatrics·C Mary Healy, Larry K Pickering
May 11, 2011·Public Health Reports·Emily F ShortridgeAngela K Shen
Mar 7, 2012·American Journal of Public Health·Melissa S StockwellVaughn I Rickert
May 9, 2012·Pediatrics·Christina A SuhAllison Kempe
Sep 21, 2012·The New England Journal of Medicine·Saad B OmerRobert A Bednarczyk
Aug 1, 2013·Human Vaccines & Immunotherapeutics·Marissa Wheeler, Alison M Buttenheim
Oct 2, 2013·Pediatrics·Jessica E AtwellSaad B Omer
Nov 6, 2013·Pediatrics·Douglas J OpelJeffrey D Robinson
Feb 13, 2014·JAMA : the Journal of the American Medical Association·Saad B OmerWalter A Orenstein
Sep 15, 2014·American Journal of Preventive Medicine·Tracy N ThomasAbigail M Shefer

❮ Previous
Next ❯

Citations

Oct 8, 2016·Current Problems in Pediatric and Adolescent Health Care·Charles ObergLeslie King-Schultz
Jul 6, 2017·Pediatric Transplantation·Clarice E CarthonBarrett R Crowther

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.